Targeting DCAF5 suppresses SMARCB1-mutant cancer via stabilizing SWI/SNF
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 24 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Samples
- 24 samples: 8 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Targeting DCAF5 suppresses SMARCB1-mutant cancer by stabilizing SWI/SNFNature · 2024
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE215022_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA888094 and SRA study SRP401521. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 23 samples.
How we read this: 8 replicated groups read from 24 sample titles; they account for 23 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM6620072 G401_ATAC_shCTRL_rep1 G401_ATAC_shCTRL
- GSM6620073 G401_ATAC_shCTRL_rep2 G401_ATAC_shCTRL
- GSM6620074 G401_ATAC_shCTRL_rep3 G401_ATAC_shCTRL
- GSM6620075 G401_ATAC_shDCAF5_rep1 G401_ATAC_shDCAF5
- GSM6620076 G401_ATAC_shDCAF5_rep2 G401_ATAC_shDCAF5
- GSM6620077 G401_ATAC_shDCAF5_rep3 G401_ATAC_shDCAF5
- GSM7747786 G401_ATAC_shCTRL_DMSO_rep1 G401_ATAC_shCTRL_DMSO
- GSM7747787 G401_ATAC_shCTRL_DMSO_rep2 G401_ATAC_shCTRL_DMSO
- GSM7747788 G401_ATAC_shCTRL_DMSO_rep3 G401_ATAC_shCTRL_DMSO
- GSM7747789 G401_ATAC_shCTRL_BRM014_rep1 G401_ATAC_shCTRL_BRM014
- GSM7747790 G401_ATAC_shCTRL_BRM014_rep2 G401_ATAC_shCTRL_BRM014
- GSM7747791 G401_ATAC_shCTRL_BRM014_rep3 G401_ATAC_shCTRL_BRM014
- GSM7747792 G401_ATAC_shDCAF5_DMSO_rep1 G401_ATAC_shDCAF5_DMSO
- GSM7747793 G401_ATAC_shDCAF5_DMSO_rep2 G401_ATAC_shDCAF5_DMSO
- GSM7747794 G401_ATAC_shDCAF5_DMSO_rep3 G401_ATAC_shDCAF5_DMSO
- GSM7747795 G401_ATAC_shDCAF5_BRM014_rep1 G401_ATAC_shDCAF5_BRM014
- GSM7747796 G401_ATAC_shDCAF5_BRMo14_rep2
- GSM7747797 G401_ATAC_shDCAF5_BRM014_rep3 G401_ATAC_shDCAF5_BRM014
- GSM7747798 ATAC_G401_dTAGDCAF5_DMSO_4h_rep1 ATAC_G401_dTAGDCAF5_DMS…
- GSM7747799 ATAC_G401_dTAGDCAF5_DMSO_4h_rep2 ATAC_G401_dTAGDCAF5_DMS…
- GSM7747800 ATAC_G401_dTAGDCAF5_DMSO_4h_rep3 ATAC_G401_dTAGDCAF5_DMS…
- GSM7747801 ATAC_G401_dTAGDCAF5_V1_4h_rep1 ATAC_G401_dTAGDCAF5_V1_…
- GSM7747802 ATAC_G401_dTAGDCAF5_V1_4h_rep2 ATAC_G401_dTAGDCAF5_V1_…
- GSM7747803 ATAC_G401_dTAGDCAF5_V1_4h_rep3 ATAC_G401_dTAGDCAF5_V1_…
- GSE215025 Targeting DCAF5 suppresses SMARCB1-mutant cancer via stabilizing SWI/SNF 94 samples shares dcaf5, swi, snf, smarcb1-mutant, stabilizing, suppresses, targeting
- GSE215023 Targeting DCAF5 suppresses SMARCB1-mutant cancer via stabilizing SWI/SNF 58 samples shares dcaf5, swi, snf, smarcb1-mutant, stabilizing, suppresses, targeting
- GSE215024 Targeting DCAF5 suppresses SMARCB1-mutant cancer via stabilizing SWI/SNF 12 samples shares dcaf5, swi, snf, smarcb1-mutant, stabilizing, suppresses, targeting
- GSE315219 PHIP suppresses NuRD to enable the growth of SWI/SNF-mutant cancers 174 samples shares swi, snf, suppresses
- GSE299672 PHIP suppresses NuRD to enable the growth of SWI/SNF-mutant cancers [ChIP-seq] 132 samples shares swi, snf, suppresses
- GSE299562 PHIP suppresses NuRD to enable the growth of SWI/SNF-mutant cancers [RNA-seq] 42 samples shares swi, snf, suppresses
- GSE323137 Targeting the CHD3 Chromatin Remodeler Exploits a Synthetic Lethal Vulnerability in SWI/SNF-Deficient Cancers via Toxic Derepression of PARD3B 39 samples shares swi, snf, targeting
- GSE313838 Androgen receptor-negative prostate cancer is vulnerable to SWI/SNF-targeting degrader molecules 32 samples shares swi, snf, targeting
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.